Gilead Sciences · 1 day ago
Sr. Director, Investor Relations
San Francisco Bay Area
Full-time
Onsite
Director/Executive
$243K/yr - $315K/yr
12+ years expGilead Sciences is dedicated to creating a healthier world for all people by tackling major diseases. The Sr. Director of Investor Relations will evolve and execute a strategic Investor Relations program, manage day-to-day responsibilities, and interact with senior executives while leading a team of five.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Manage quarterly earnings process and deliverables including script, deck and Q&A materials
Design and execute an impactful investor engagement program, including investor conferences, non-deal roadshows, analyst days, annual meeting, on-site meetings and other events
Deliver concise and impactful communications to support Gilead participation at scientific conferences and pre-clinical or clinical data updates
Support executives’ participation at investor conferences, including preparation of Q&A materials and travel to conferences
Conduct peer and competitive analysis of clinical pipelines and business models
Innovate and evolve IR program but always in full compliance with all regulatory requirements surrounding investor communications
Deliver highly responsive and accurate communications to in-bound inquiries from all stakeholders (sell-side, buy-side, retail, employees, executives)
Qualification
Required
Typically requires a BA degree in Finance, Science or relevant field and minimum 14 years of relevant experience or an MBA with 12 years of relevant experience and/or CFA
Excellent attention to detail, with very strong verbal and interpersonal communication skills
Expert in excel and PowerPoint, with ability to understand and interpret financial statements and valuation models
Must be able to independently develop clear, concise and error-free word, PowerPoint and excel documents
Ability to work independently, lead meetings and work cross-functionally
Manage quarterly earnings process and deliverables including script, deck and Q&A materials
Design and execute an impactful investor engagement program, including investor conferences, non-deal roadshows, analyst days, annual meeting, on-site meetings and other events
Deliver concise and impactful communications to support Gilead participation at scientific conferences and pre-clinical or clinical data updates
Support executives' participation at investor conferences, including preparation of Q&A materials and travel to conferences
Conduct peer and competitive analysis of clinical pipelines and business models
Innovate and evolve IR program but always in full compliance with all regulatory requirements surrounding investor communications
Deliver highly responsive and accurate communications to in-bound inquiries from all stakeholders (sell-side, buy-side, retail, employees, executives)
Create Inclusion - knowing the business value of diverse teams, modeling inclusion, and embedding the value of diversity in the way they manage their teams
Develop Talent - understand the skills, experience, aspirations and potential of their employees and coach them on current performance and future potential
Empower Teams - connect the team to the organization by aligning goals, purpose, and organizational objectives, and holding them to account
Preferred
Experience in the biotech or pharmaceutical industry (and in analyzing and summarizing clinical data) are preferred but not essential
Experience in investor relations is preferred but not essential
Benefits
Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
10001+ employees
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Keeley Wettan
Senior Vice President, Legal
Patrick Loerch
Senior Vice President, Clinical Data Science
Recent News
2026-01-09
2026-01-08
2026-01-07
Company data provided by crunchbase